SIGMAR1 and amyotrophic lateral sclerosis: Previous studies have demonstrated that Sig-1R agonists exert neuroprotective effects in various neurodegenerative diseases, such as ALS, Huntington’s disease, Parkinson’s disease, and Alzheimer’s disease [7, 12–14].